XBIRA 250mg (Abiraterone Acetate) is a prescription drug used for treating a certain type of prostate cancer that has spread to other parts of the body. XBIRA contains Abiraterone acetate which belongs to a class drugs known as antiandrogens. It stops the body from making testosterone which can slow the growth of prostate cancer.
Manufactured : Cipla Ltd
Strengths available : 250mg tablets
Storage : Store below 30°C
The recommended dose of XBIRA tablets is 1000mg (four 250mg tablets) administered orally once daily in combination with Prednisone 5mg administered orally twice daily.
XBIRA tablets must be taken on an empty stomach. No food should be consumed for at least 2 hours before the dose of XBIRA tablets is taken and for at least 1 hour after the dose of XBIRA tablets is taken.
The tablets should be swallowed whole with water and not to be crushed or chewed. It is highly advisable to administer the drug under strict medical supervision and advice.
Most common side effects are Decreased potassium level in blood, Edema, Increased blood pressure, Urinary tract infection, Diarrhoea